SUBSCRIBE
SUBSCRIBE

Newsfile Corp

IN THE PRESS
Awakn Life Sciences Reports Strong Q3 2022 Results with 27% Revenue Growth
December 15, 2022
 · 
7 min read
NovelStem’s Affiliate NewStem Announced New Collaboration to Validate Its Software Diagnostic Device for Two Oncology Indications and Two Therapies
December 14, 2022
 · 
5 min read
ScreenPro Announces Closing of Non-Brokered Private Placement Financing
December 14, 2022
 · 
4 min read
Business
Skye Bioscience Appoints Chris Twitty, PhD, as Chief Scientific Officer
December 13, 2022
 · 
4 min read
Drug Development
Awakn Life Sciences’ Phase III Trial to Be Delivered in the UK National Health Service (NHS)
December 13, 2022
 · 
6 min read
Business
American Aires Announces Appointment of Chief Financial Officer
December 12, 2022
 · 
3 min read
Policy
Octaviant Financial Introduces Specialized Loan and Therapeutic Warranty Solutions to Help BioPharma, Payers and Insurers Expand Access to Innovative Therapies
December 12, 2022
 · 
1 min read
FDA
Marvel Biosciences Initiates Its Final FDA-Required Experiment Prior to Initiating Human Trials for Its Lead Drug Candidate MB-204
December 12, 2022
 · 
5 min read
Business
Telo Genomics Appoints Kris Weinberg as Chief Executive Officer
December 12, 2022
 · 
6 min read
Drug Development
Cardiol Therapeutics Commences Multi-Center Phase II Pilot Study of CardiolRx(TM) for the Treatment of Recurrent Pericarditis
December 12, 2022
 · 
7 min read
Load More
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us